powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1013476969
Rachel Sheskier
Endocrinology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 330024
Hospital
CCN 330046
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
130
Beneficiaries
—
Total drug cost
$82K
Distinct drugs
9
Brand share
100.0%
Top prescribed drugs
Semaglutide
20 claims
Alcohol Antiseptic Pads
16 claims
Empagliflozin
16 claims
Dapagliflozin Propanediol
15 claims
Metformin Hcl
13 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
92
Unique beneficiaries
—
Total services
99
Distinct HCPCS
6
Medicare payment
$10K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 627 Endocrinology providers in NY — bottom quintile (cohort median 837).